Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Day One Biopharmaceuticals (DAWN) Tax Provisions (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Tax Provisions for 2 consecutive years, with -$2.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Tax Provisions fell 130.73% to -$2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.0 million, a 127.83% decrease, with the full-year FY2025 number at -$2.0 million, down 127.83% from a year prior.
  • Tax Provisions was -$2.0 million for Q4 2025 at Day One Biopharmaceuticals, down from $6.4 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $6.4 million in Q4 2024 to a low of -$2.0 million in Q4 2025.